The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7528106 B1

PDF
Full Text
Expired
Date of Patent:
May. 05, 2009

Filed:

Jun. 06, 2005
Applicants:

Martin Friedlander, Del Mar, CA (US);

Hilda Edith Aguilar, San Diego, CA (US);

Michael I. Dorrell, San Diego, CA (US);

Inventors:

Martin Friedlander, Del Mar, CA (US);

Hilda Edith Aguilar, San Diego, CA (US);

Michael I. Dorrell, San Diego, CA (US);

Assignee:

The Scripps Research Institute, La Jolla, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 31/7088 (2006.01); C07K 14/00 (2006.01); C07H 21/00 (2006.01); A61K 31/535 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides compositions and methods of treating neovascular diseases, such as a retinal neovascular diseases and tumors, by administering to a patient suffering from a neovascular disease or tumor a vascular development inhibiting amount of a combination of the angiogenesis suppressing drugs comprising an angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS) and at least one compound selected from the group consisting of a vascular endothelial growth factor (VEGF) signaling inhibitor and an integrin signaling inhibitor. Compositions for use in the methods include an admixture of an angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS) and at least one of a vascular endothelial growth factor (VEGF) signaling inhibitor and an integrin signaling inhibitor, together with a pharmaceutically acceptable excipient.


Find Patent Forward Citations

Loading…